Try our Advanced Search for more refined results
December 12, 2008
Track this case
New York Eastern
Carol Bagley Amon
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Drugmaker Nycomed US Inc. reached a settlement in New York on Wednesday in its patent dispute with Glenmark Generics Ltd. that will block Glenmark from producing a generic version of Nycomed's Cutivate skin treatment until March 2012.
Already a subscriber? Click here to login